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Chemotherapy is a major cancer treatment option. The synthesis of new compounds with better 
anti-proliferative properties and higher specificity is a current challenge in drug discovery today. 
Our goal with this work was to develop compounds derived from D-glucuronic acid and to 
evaluate their anti-proliferative properties. We have synthetized a library of hydroxyamide 
derivatives of D-glucuronic acid using amines and aminoalcohols. The synthesis of these 
compounds were based on the work of El-Nezhawy's group, who have designed some novel D-
glucuronic acid acetylated and deacetylated derivatives, which showed interesting results with 
breast cancer cell lines. 
Anti-proliferative activity of the newly synthesized compounds was examined against human 
breast adenocarcinoma (MCF-7) and human colon carcinoma (MDST8) cell lines. Cell growth 
and viability was analysed by the Cell Counting Kit-8 method. The chemotherapeutic agent 5-
fluoroacil was used as a positive control, allowing one to estimate the maximal anti-
proliferative action expected in both carcinoma cell lines. All the compounds were studied in 
the 10-9-10-5M range. 
The compound N-(ethanol)-α/β D-glucopyranuronamide presented the best anti-proliferative 
potential with an IC50 (concentration of the compound causing 50% decrease in net cell growth) 
of 1.4x10-7M in MCF-7 cells. The 1-pheny-l-2-hydroxy-ethane-2-yl and the 1-propanol 
derivatives evoked weak anti-proliferative effects in MCF-7, with slight growth inhibition of 
37% and 35%, respectively, for the highest concentration used (10-5M). On the contrary, the 
MDST-8 cell growth was not affected by these compounds. On the contrary, the 1-hydroxy-2-
isopropyl-ethane-2-yl and 3-phenyl-1-hydroxy-propane-2-yl derivatives, exhibited weak anti-
proliferative effects (22% and 40%, respectively) at 10-5M, in the MDST8 cell line, without 
affecting MCF-7 cell growth. None of the compounds exihibited toxic effects, at least up to 72h 
exposure, in the concentration range studied. 
These results show that the ethyl substituent was the most effective N-substituent for 
glucopyranuronamide for anti-proliferative actions in MCF-7 cell line, whilst in the case of the 
MDST8 cells, 3-phenyl-1-hydroxy-propane-2-yl was the most effective N-substituent. Moreover, 
all the glucopyranonamide compounds studied presented selective anti-proliferative effects for 
the different carcinoma cell lines used.  
 
